Breaking News , Biophysics Blurb
November 28, 2023
Allosteric Competition and Inhibition!
Small molecule therapeutics alter the three-dimensional landscape of glutamate receptors to control neurotransmission in disease states. We outline how therapeutic candidates inhibit glutamate receptors, and also observe a new phenomenon called allosteric competition, where two small molecules compete to control receptor function. Our findings provide a new framework for us to understand three-dimensional control of receptor function and provide new foundations for rational drug design. Read more in our preprint, linked below!
https://www.biorxiv.org/content/10.1101/2023.11.28.569057v1
Tags:
Related Posts
- An expanded role for how the FDA-approved drug memantine functions. ( July 24, 2024 )
- Congrats, Calli! ( December 18, 2023 )
- First publication! ( December 15, 2023 )
- How to tune neurotransmitter function ( November 28, 2023 )
- Why Time-Resolved Cryo-EM? ( September 16, 2023 )
- First preprint! ( September 6, 2023 )
- Lucas passed his GBO! Congrats, Lucas! ( May 9, 2023 )
- The lab goes to Top Golf! ( April 14, 2023 )
- Summer kayaking and paddle boarding! ( August 17, 2022 )
- Lucas joins the lab for his PhD! ( August 8, 2022 )
About the Author
The Author has not yet added any info about himself